ATTR-CM, or transthyretin amyloid cardiomyopathy, is a serious but often underdiagnosed heart condition. It occurs when misfolded proteins called amyloid fibrils build up in the heart muscle, making it stiff and less able to pump blood efficiently. Because its symptoms can resemble many other common conditions, ATTR-CM is frequently overlooked or mistaken for something else. Understanding its signs is critical for early detection and better outcomes.
What Is ATTR-CM?
ATTR-CM is caused by the abnormal folding of a protein called transthyretin (TTR), which is primarily produced in the liver. When TTR misfolds, it clumps together and deposits as amyloid in heart tissue. Over time, these deposits thicken and stiffen the walls of the heart, particularly the ventricles, impairing normal cardiac function.
There are two main forms of the disease. The hereditary form (hATTR-CM) is caused by a genetic mutation passed down through families. The wild-type form (wtATTR-CM) occurs due to aging and is not inherited. Wild-type ATTR-CM is far more common than previously believed and primarily affects older adults, especially men over the age of 60.
Why Is ATTR-CM Often Missed?
One of the most significant challenges with ATTR-CM is that its symptoms closely mimic those of other heart and musculoskeletal conditions. Many patients are initially diagnosed with hypertensive heart disease, hypertrophic cardiomyopathy, or simply age-related changes. This overlap leads to substantial diagnostic delays, sometimes spanning years.
Increased awareness among both physicians and the general public is essential. If certain combinations of symptoms are present — particularly in older adults — ATTR-CM should be considered as a possible cause.
Primary Cardiac Signs
The heart is the central organ affected in ATTR-CM, so most of the defining symptoms stem from deteriorating cardiac function. These signs reflect the progressive stiffening and weakening of the heart muscle over time.
Shortness of Breath
Dyspnea, or difficulty breathing, is one of the most common and earliest symptoms of ATTR-CM. Patients often notice breathlessness during everyday activities such as walking, climbing stairs, or carrying groceries. As the disease progresses, shortness of breath may occur even at rest.
This symptom results from fluid backing up into the lungs because the stiff heart cannot fill and pump blood properly. It is frequently mistaken for general deconditioning or other lung conditions, contributing to delayed diagnosis.
Fatigue and Reduced Exercise Tolerance
Persistent fatigue is another hallmark symptom. People with ATTR-CM often find that activities they once performed easily have become exhausting. This occurs because the heart cannot deliver adequate blood and oxygen to the body's tissues during physical exertion.
Many patients gradually adapt by reducing their activity levels, which can mask the progression of the disease and delay medical evaluation.
Swelling in the Legs and Ankles
Peripheral edema, or swelling in the lower extremities, is a common sign of heart failure associated with ATTR-CM. When the heart fails to pump effectively, fluid accumulates in the legs, ankles, and feet. This swelling is often worse at the end of the day and may improve after lying down overnight.
Some patients also experience abdominal bloating or a feeling of fullness, which can result from fluid buildup in the abdomen.
Heart Failure with Preserved Ejection Fraction (HFpEF)
Many patients with ATTR-CM are diagnosed with a specific type of heart failure known as HFpEF. In this condition, the heart's pumping function (ejection fraction) appears normal, but the heart is too stiff to fill properly with blood. ATTR-CM is an important and underrecognized cause of HFpEF, particularly in older individuals.
Irregular Heart Rhythms
Arrhythmias are significantly more common in people with ATTR-CM than in the general population. Atrial fibrillation (AFib), in particular, frequently co-exists with ATTR-CM. Patients may experience palpitations, a fluttering sensation in the chest, dizziness, or fainting spells.
Conduction abnormalities, which affect the electrical pathways of the heart, are also prevalent. These may require the implantation of a pacemaker. Sudden cardiac death, while less common, is a serious risk in advanced cases.
Low Blood Pressure Upon Standing
Orthostatic hypotension, a sudden drop in blood pressure when standing up, can occur in ATTR-CM. This can cause lightheadedness, dizziness, or fainting. It may also complicate medication management, as drugs typically used for heart failure can worsen this symptom.
Non-Cardiac Signs and Red Flags
One distinguishing feature of ATTR-CM — especially the hereditary form — is the presence of symptoms outside the heart. These non-cardiac manifestations can appear before cardiac symptoms develop and serve as important early warning signs.
Carpal Tunnel Syndrome
Bilateral carpal tunnel syndrome, particularly when it occurs in both wrists and requires surgical release, is a well-recognized early warning sign of ATTR-CM. Studies have found that a significant proportion of patients who present with bilateral carpal tunnel syndrome before age 70 go on to develop ATTR-CM.
The amyloid protein can deposit in the tendons and ligaments of the wrist, compressing the median nerve. This may precede cardiac symptoms by five to ten years, making it a valuable diagnostic clue.
Spinal Stenosis
Lumbar spinal stenosis, a narrowing of the spinal canal that causes back pain and leg weakness, has been associated with ATTR-CM. As with carpal tunnel syndrome, amyloid deposits in spinal structures can contribute to this condition.
Patients who have undergone spinal surgery for stenosis and later develop heart failure should be evaluated for ATTR-CM, particularly if other risk factors are present.
Peripheral Neuropathy
In hereditary ATTR-CM, amyloid can affect the peripheral nervous system, causing polyneuropathy. Symptoms include numbness, tingling, burning sensations, or pain in the hands and feet. Some patients experience weakness in their limbs.
Autonomic neuropathy — affecting the nerves that control automatic body functions — can also occur, leading to digestive problems, urinary issues, or sexual dysfunction.
Gastrointestinal Symptoms
Some patients with hATTR-CM experience significant gastrointestinal disturbances, including nausea, diarrhea, constipation, or alternating bowel habits. These symptoms result from amyloid deposits affecting the nerves and smooth muscle of the digestive tract.
Unexplained weight loss is also sometimes reported and can be a sign of advanced disease.
Eye Abnormalities
In hereditary ATTR-CM, amyloid deposits can occur in the vitreous of the eye, causing visual disturbances. This is known as vitreous opacities. Patients may notice floaters or blurred vision.
Abnormal blood vessel development on the surface of the retina has also been described, though these findings are more typical of specific genetic mutations associated with hATTR.
Clues Found During Medical Testing
ATTR-CM often leaves distinct footprints in routine and specialized medical tests. These findings, when combined with symptoms, can point clinicians toward the correct diagnosis.
Electrocardiogram (ECG) Findings
An ECG in patients with ATTR-CM often shows low-voltage patterns, meaning the electrical signals appear smaller than expected despite the heart muscle being thickened. This paradox — a thick heart producing low ECG voltage — is an important diagnostic clue.
Conduction disturbances such as bundle branch blocks or atrioventricular blocks may also be visible on an ECG, reflecting amyloid infiltration of the heart's electrical system.
Echocardiogram Findings
An echocardiogram (cardiac ultrasound) typically reveals a thickened heart muscle (increased wall thickness), a small or normal-sized left ventricular cavity, and diastolic dysfunction. A sparkling or granular appearance of the heart muscle may also be noted, though this finding is not specific to ATTR-CM.
These findings, taken together, suggest a diagnosis of infiltrative cardiomyopathy and warrant further investigation.
Elevated Cardiac Biomarkers
Blood tests often reveal elevated levels of cardiac biomarkers such as NT-proBNP (or BNP) and troponin. These markers indicate heart muscle stress and injury. While not specific to ATTR-CM, elevated levels in a patient with suspected amyloid features add weight to the diagnosis.
Who Is at Highest Risk?
Certain groups are at significantly higher risk for developing ATTR-CM and should be particularly vigilant about recognizing symptoms.
Older Adults
Wild-type ATTR-CM predominantly affects men over the age of 60, with prevalence increasing sharply with age. Some autopsy studies have found amyloid deposits in the hearts of a substantial proportion of people over age 80, suggesting the condition may be far more widespread than current diagnosis rates reflect.
People of West African Descent
A specific genetic mutation called Val122Ile (V122I) is found in approximately 3 to 4 percent of people with West African ancestry. This variant significantly increases the risk of hereditary ATTR-CM. Individuals from this background who develop unexplained heart failure should be screened for this mutation.
Individuals with a Family History
People who have a first-degree relative diagnosed with hATTR-CM or hATTR polyneuropathy should consider genetic counseling and testing. The earlier a mutation is identified, the sooner monitoring and treatment can begin.
The Importance of Early Recognition
Recognizing the signs of ATTR-CM early has never been more important. Advances in non-invasive diagnostic testing, including nuclear bone scintigraphy (a specialized heart scan), have made it possible to diagnose ATTR-CM without a biopsy in many cases. Additionally, disease-modifying therapies are now available that can slow the progression of the disease.
Tafamidis, a medication that stabilizes the TTR protein, has been shown to reduce mortality and hospitalizations in patients with ATTR-CM. Other treatments are under active investigation. The earlier treatment begins, the greater the potential benefit.
When to See a Doctor
Anyone experiencing unexplained shortness of breath, fatigue, leg swelling, or irregular heartbeats — especially in combination with a history of carpal tunnel syndrome, spinal stenosis, or a family history of heart or nerve disease — should speak with a healthcare provider. Mentioning these combinations of symptoms can prompt a physician to consider ATTR-CM as a possible diagnosis.
Referral to a cardiologist with experience in amyloid heart disease is recommended for further evaluation if ATTR-CM is suspected.
Summary of Key Signs to Watch For
The signs of ATTR-CM span both cardiac and non-cardiac systems. Key warning signs include unexplained heart failure (particularly HFpEF), breathlessness, fatigue, leg swelling, irregular heart rhythms, bilateral carpal tunnel syndrome, spinal stenosis, peripheral neuropathy, and gastrointestinal disturbances. Diagnostic red flags on testing include low ECG voltage with thickened heart walls, diastolic dysfunction on echocardiogram, and elevated cardiac biomarkers.
Awareness of these signs — and advocating for thorough evaluation when they appear — can make a meaningful difference in diagnosis, treatment, and quality of life for those affected by this underrecognized condition.
